Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective study

BACKGROUND: Recently, a prospective study reported improved clinical outcomes for recurrent ovarian cancer patients treated with chemotherapies indicated to be sensitive by a chemoresponse assay, compared with those patients treated with non-sensitive therapies, thereby demonstrating the assay'...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, C, Sargent, D J, Krivak, T C, Powell, M A, Gabrin, M J, Brower, S L, Coleman, R L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150278/
https://www.ncbi.nlm.nih.gov/pubmed/25003664
http://dx.doi.org/10.1038/bjc.2014.375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150278/
https://www.ncbi.nlm.nih.gov/pubmed/25003664
http://dx.doi.org/10.1038/bjc.2014.375

Ejemplares similares